D.E. Shaw & Co
ASTH icon

D.E. Shaw & Co’s Astrana Health ASTH Stock Holding History

D.E. Shaw & Co’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$390K – 5182
2022
Q3 		$390K Hold
10,000
– – ﹤0.01% 4190
2022
Q2 		$386K Sell
10,000
-17,200
-63% -$654K ﹤0.01% 4245
2022
Q1 		$1.32M Hold
27,200
– – ﹤0.01% 3681
2021
Q4 		$2M Buy
+27,200
New +$2.23M ﹤0.01% 3363

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co's ASTH Position: Q4 2025 in Review

D.E. Shaw & Co sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 145,556 shares — an estimated $4.13M sold.

D.E. Shaw & Co first reported a position in ASTH in Q4 2020 and held it in 3 quarters. The position peaked at $4.13M in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • D.E. Shaw & Co reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 145,556 Astrana Health shares in Q4 2025, an estimated $4.13M.
  • D.E. Shaw & Co first reported a position in Astrana Health in Q4 2020 and held it in 3 quarters.
  • D.E. Shaw & Co's Astrana Health position peaked at $4.13M in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.